Epizyme, inc. (EPZM)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-50,937

-56,402

-36,089

-48,465

-29,339

-22,945

-37,492

-29,128

-34,065

-36,166

-37,597

-28,024

-32,522

-35,016

-24,336

-27,981

-22,879

-22,226

-23,065

-25,759

-61,326

-15,035

-19,700

-13,386

-6,884

15,930

-9,704

-2,212

-7,497

Adjustments to reconcile net loss to net cash used in operating activities:
Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

40,000

-

-

-

0

-

-

-

-

Depreciation and amortization

512

174

210

209

207

296

222

221

361

409

406

413

411

400

398

402

389

361

405

393

260

194

186

193

169

169

171

184

179

Stock-based compensation

6,510

6,400

3,677

4,728

3,211

2,490

3,203

3,424

2,887

2,758

2,895

3,021

2,757

2,725

2,717

2,753

2,373

2,083

2,856

2,494

2,416

2,186

1,583

1,632

1,463

1,000

869

615

335

Amortization of discount on investments

270

468

948

1,069

690

512

479

459

106

-420

86

51

18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount

83

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-19

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense associated with the sale of future royalties

295

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-22

1

0

-6

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-918

-9,433

-1,273

296

-7,090

7,724

12,344

-24

-358

357

0

17

-15

-6,177

6,140

-116

-86

85

-546

358

-1,710

-34

-82

-5,960

-25,516

31,512

-5,653

5,906

73

Inventory

1,703

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

7,104

-555

1,972

-1,109

3,051

5,154

-1,504

-401

-68

-825

1,403

-283

2,230

978

-2,531

2,105

990

1,974

493

-524

-305

-433

617

578

-343

180

109

1,191

15

Accounts payable

-2,716

2,816

-1,519

-1,082

3,174

-1,703

-4,689

3,762

226

1,601

-4,234

2,687

1,913

1,607

-286

1,437

-2,417

1,681

-116

-2,011

-3,201

2,504

1,249

1,179

-1,321

1,277

74

-1,234

1,524

Accrued expenses

-4,489

3,266

1,603

2,302

-4,274

-793

2,240

766

-147

336

1,049

3,715

-3,577

4,623

443

1,214

-1,607

-746

2,605

4,281

-1,848

-1,609

2,430

1,394

-1,804

1,252

1,013

389

-350

Deferred revenue

-

-1,794

-4,465

850

-7,891

-

-

-

-

-

-

-

-

-478

-478

-472

-472

-555

9,641

-597

-931

-9,999

-4,335

-3,742

-5,645

-3,834

-6,231

-6,280

-6,228

Operating lease assets

-733

11,837

-661

-312

-943

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-155

12,012

-679

-327

-963

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-36

-

-17

144

-21

-

0

-18

36

0

-3

16

4

-18

28

1

-117

149

-107

52

84

-380

-57

-136

-33

-283

-57

-59

832

Other liabilities

-

-

-

-

-

-

17

83

113

150

74

76

20

-55

-41

-40

-46

-21

-12

7

-18

-55

1

3

5

-90

-137

-1,085

-67

Acquisition of in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

40,000

-

-

-

0

-

-

-

-

Net cash used in operating activities

-58,268

-35,484

-38,231

-41,891

-31,562

-22,553

-35,818

-32,888

-30,341

-30,392

-38,893

-17,913

-33,235

-20,976

-25,245

-24,704

-25,446

-21,609

-7,527

-21,078

-22,711

-20,965

-19,064

-7,209

11,875

-15,705

-8,344

-16,661

-13,024

Purchases of available-for-sale securities

13,999

-

45,269

124,753

173,151

-

32,101

64,925

100,763

-

34,723

40,061

40,785

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of available-for-sale securities

58,578

-

131,768

67,828

100,720

-

65,796

35,346

32,988

-

51,917

82,352

58,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of intangible asset

25,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

63

171

233

169

21

147

43

1

108

247

54

565

118

204

101

249

70

-5

-41

66

163

986

406

508

316

400

0

190

40

Net cash provided by (used in) investing activities

19,516

-42,040

86,266

-57,094

-72,452

-38,795

33,652

-29,580

-67,883

37,167

17,140

41,726

17,297

32,782

1,564

-199,690

-70

5

41

-66

-40,163

-986

-406

-508

-316

-400

0

-190

-40

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of commissions

-

-1

0

0

122,992

-

-

-

-

2

151,333

0

1,587

371

0

0

130,067

0

0

13,682

117,030

0

0

0

101,283

-

-

-

-

Proceeds from issuance of preferred stock, net of commissions

-

-1

0

1

37,432

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of offering costs

79

0

20

242

22

-

-

-

-

-

-

-

-

109

0

0

374

0

0

337

30

0

0

181

468

40

773

1,998

38

Proceeds from the issuance of debt

25,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

90

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of common stock in connection with the exercise of the put option, net of financing costs

49,915

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from reimbursement of common stock offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

269

-

-

-

-

Payment under capital lease obligation

-

-

-

-

-

0

0

19

110

160

157

153

150

145

142

139

135

132

128

126

55

-

-

-

-

-

-

-

-

Proceeds from stock options exercised

3,140

436

183

853

886

62

219

104

1,500

643

1,510

487

641

-56

147

1,357

141

121

660

116

99

388

1,014

684

650

106

3

0

168

Issuance of shares under employee stock purchase plan

646

1

380

0

360

0

320

0

459

-2

332

1

346

0

224

0

150

0

197

0

239

0

253

0

201

-

-

-

-

Net cash provided by financing activities

78,532

123,543

543

612

161,648

81,740

539

85

1,849

95

153,018

335

2,424

61

229

1,218

129,849

-11

729

13,335

117,283

377

1,267

531

101,935

94

-770

80,493

130

Net increase in cash, cash equivalents and restricted cash

39,780

46,019

48,578

-98,373

57,634

20,392

-1,627

-62,383

-96,375

6,870

131,265

24,148

-13,514

11,867

-23,452

-223,176

104,333

-21,615

-6,757

-7,809

54,409

-21,574

-18,203

-7,186

113,494

-16,011

-9,114

63,642

-12,934

SUPPLEMENTAL CASH FLOW INFORMATION:
Equipment acquired under capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,732

-

-

-

-

-

-

-

-

Unpaid offering costs

-

-

-

-

262

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

338

-

-

-

183

-

-761

-455

1,222

Interest paid

914

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment included in accounts payable or accruals

22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

421

-157

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

241

-

-

-

-

Purchases of property and equipment unpaid at period end

-

-

-

-

-

-

-

44

44

-

-

-

438

-

-

-

-

-

-

-

-

-

-

-214

327

-

192

-21

21